Former U.S. President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones, according to a statement released by his medical team on Friday.
The diagnosis followed medical evaluations prompted by urinary symptoms. A subsequent examination revealed a prostate nodule, which was later confirmed to be malignant. The cancer has been classified with a Gleason score of 9, indicating a high-grade and aggressive nature.
Despite the severity of the illness, doctors noted that the cancer is hormone-sensitive—meaning it can be managed with treatments such as hormone therapy. Given Biden’s age and the advanced stage of the disease, surgery is not considered a viable option. His medical team is currently exploring non-surgical treatments to slow the progression of the disease and maintain quality of life.
Prostate cancer remains the second-leading cause of cancer-related deaths among American men. While early detection has significantly improved survival rates, cases of late-stage diagnoses like Biden’s are still a concern.
Following the announcement, an outpouring of support flooded in from across the political spectrum. Former President Donald Trump expressed his sympathy, stating he and former First Lady Melania Trump were “saddened to hear about Joe Biden’s recent medical diagnosis” and wished him a “fast and successful recovery.”
Former Vice President Kamala Harris also shared her support, saying that she and her husband, Doug Emhoff, are keeping the Biden family in their prayers.
Biden’s diagnosis reignites national conversations around health and ageing in political leadership. As the oldest individual to have served as President of the United States, his health has long been the subject of public and political scrutiny. This latest development highlights the importance of regular medical screenings and early intervention, especially among older populations.
